Lewis Strauss

Lewis Strauss

UNVERIFIED PROFILE

Are you Lewis Strauss?   Register this Author

Register author
Lewis Strauss

Lewis Strauss

Publications by authors named "Lewis Strauss"

Are you Lewis Strauss?   Register this Author

15Publications

356Reads

34Profile Views

Optimization of combination therapy for chronic myeloid leukemia with dosing constraints.

J Math Biol 2018 11 10;77(5):1533-1561. Epub 2018 Jul 10.

Department of Mathematics and Statistics, Southern Illinois University Edwardsville, Edwardsville, IL, 62026-1653, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00285-018-1262-6DOI Listing
November 2018

Radiation-agent combinations for glioblastoma: challenges in drug development and future considerations.

J Neurooncol 2017 Sep 30;134(3):551-557. Epub 2017 May 30.

Radiation Research Program, National Cancer Institute, Bethesda, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-017-2458-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5709276PMC
September 2017

Implementation of Amplicon Parallel Sequencing Leads to Improvement of Diagnosis and Therapy of Lung Cancer Patients.

J Thorac Oncol 2015 Jul;10(7):1049-57

*Institute of Pathology, University Hospital of Cologne, Cologne, Germany; †Center for Integrated Oncology Cologne/Bonn, University Hospital of Cologne, Cologne, Germany; ‡Lung Cancer Group Cologne, Department I for Internal Medicine, University Hospital of Cologne, Cologne, Germany; §Labor Dr. Quade und Kollegen GmbH, Cologne, Germany; ‖Institute of Human Genetics, University of Cologne, Cologne, Germany; ¶Targos Molecular Pathology GmbH, Kassel, Germany; #Department of Translational Genomics, University of Cologne, Cologne, Germany; **Cologne Center for Genomics, Cologne, Germany; ††GENterprise GENOMICS GmbH, Mainz, Germany; ‡‡Bristol-Myers Squibb R&D, Princeton, New Jersey; §§Evangelische Kliniken Johanniter, Bonn, Germany; ‖‖Malteser Krankenhaus, Lung Cancer Center, Bonn, Germany; ¶¶Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany; ##Institute for Hematopathology Hamburg, Hamburg, Germany; and ***New Oncology, Cologne, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000570DOI Listing
July 2015

A phase 1 study of gemcitabine combined with dasatinib in patients with advanced solid tumors.

Invest New Drugs 2013 Aug 20;31(4):918-26. Epub 2012 Nov 20.

Department of Investigational Cancer Therapeutics, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10637-012-9898-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4482128PMC
August 2013

Dasatinib as a single agent in triple-negative breast cancer: results of an open-label phase 2 study.

Clin Cancer Res 2011 Nov 25;17(21):6905-13. Epub 2011 Oct 25.

Department of Medicine, Division of Hematology, Oncology, Geffen School of Medicine, UCLA Medical Center, Los Angeles, California 90095, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-11-0288DOI Listing
November 2011

Pediatric phase I trial and pharmacokinetic study of dasatinib: a report from the children's oncology group phase I consortium.

J Clin Oncol 2011 Mar 24;29(7):839-44. Epub 2011 Jan 24.

MSCE, The Children's Hospital of Philadelphia, Pediatric Oncology/Stem Cell Transplant, Philadelphia, PA 19104-4318, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2010.30.7231DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3068059PMC
March 2011

Outcomes of a two-drug chemotherapy regimen for intraocular retinoblastoma.

Pediatr Blood Cancer 2008 Mar;50(3):567-72

Division of Hematology/Oncology/Transplantation, Children's Memorial Hospital, Chicago, Illinois, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.21301DOI Listing
March 2008